Fiduciary Alliance’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Sell
7,575
-13,328
-64% -$3.69M 0.11% 200
2026
Q1
$6.21M Sell
20,903
-4,223
-17% -$1.25M 0.37% 67
2025
Q4
$6.86M Buy
25,126
+2,435
+11% +$662K 0.45% 56
2025
Q3
$6.13M Sell
22,691
-1,092
-5% -$297K 0.41% 61
2025
Q2
$6.55M Sell
23,783
-73
-0.3% -$19.9K 0.49% 55
2025
Q1
$6.33M Buy
23,856
+371
+2% +$91.5K 0.62% 40
2024
Q4
$5.45M Buy
23,485
+3,571
+18% +$821K 0.55% 53
2024
Q3
$4.39M Sell
19,914
-3
-0% -$621 0.58% 47
2024
Q2
$3.93M Buy
19,917
+4,867
+32% +$1.01M 0.64% 46
2024
Q1
$3.19M Buy
+15,050
New +$3.16M 0.56% 52
2023
Q3
Sell
-129
Closed -$24K 298
2023
Q2
$24K Buy
+129
New +$23.8K 0.01% 416
2023
Q1
Sell
-32
Closed -$5.43K 274
2022
Q4
$5.43K Buy
+32
New +$5.56K ﹤0.01% 507

Other funds holding CME

Fiduciary Alliance's CME Position: Q2 2026 in Review

Fiduciary Alliance reduced its CME Group (CME) stake by 64% in Q2 2026, selling an estimated $3.69M and leaving 7,575 shares worth $1.67M. The position accounts for 0.11% of the portfolio, ranked #200.

Fiduciary Alliance first reported a position in CME in Q4 2022 and has held it in 12 quarters since. The position peaked at $6.86M in Q4 2025. 308 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Fiduciary Alliance held 7,575 shares of CME Group worth $1.67M as of Q2 2026.
  • Fiduciary Alliance sold 13,328 CME Group shares in Q2 2026, an estimated $3.69M.
  • CME Group made up 0.11% of Fiduciary Alliance's portfolio in Q2 2026, its #200 holding.
  • Fiduciary Alliance first reported a position in CME Group in Q4 2022 and has held it in 12 quarters since.
  • Fiduciary Alliance's CME Group position peaked at $6.86M in Q4 2025.
  • 308 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.